India to Vietnam: Syringe Export Trade Route

The India to Vietnam Syringe corridor is one of India's established pharmaceutical export routes, with 93 shipments documented worth a combined $7.0M USD. The route is dominated by INDIAN IMMUNOLOGICALS LIMITED, which alone accounts for roughly 90% of all export value, reflecting the consolidated nature of India's syringe manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $75.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with syringe's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 11.6%, placing it at rank #1 among India's top syringe export destinations globally.

On the import side, key buyers of Indian syringe in Vietnam include DUC MINH MEDICAL JOINT STOCK COMPAN, DUC MINH MEDIACL JOINT STOCK COMPAN, DUC MINH MEDICAL JOINT STOCK and 10 others. DUC MINH MEDICAL JOINT STOCK COMPAN is the single largest importer with 20 shipments valued at $4.4M USD.

India's syringe exports to Vietnam are driven primarily by a handful of large-scale manufacturers. INDIAN IMMUNOLOGICALS LIMITED with 33 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Vietnam benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INDIAN IMMUNOLOGICALS LIMITED, INDIAN IMMUNOLOGICALS LTD, HEIL PHARMA — together account for 99% of total trade value on this route. The average shipment value of $75.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as abhayrab 0 5ml human rabies vaccine withdiluent and syringe and abhayrab 0.5ml(human rabies vaccine other single vaccine with diluent and syringe), suggesting that buyers in Vietnam tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, DUC MINH MEDICAL JOINT STOCK COMPAN is the largest importer with 20 shipments worth $4.4M USD — representing 63% of all syringe imports from India on this route. A total of 13 buyers are active on this corridor.